InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:

BENITEC LIMITED (BLT)
(This company subsequently changed its name to BENITEC BIOPHARMA LIMITED. You should refer to that name for Status.)

Date of Listing:

17 February 1997

Subsequent Names:

Company Name	Start Date	End Date
BENITEC BIOPHARMA LIMITED	25/11/2011

Former Names:

Stock Exchange Status: (updated daily)

This company subsequently changed its name to BENITEC BIOPHARMA LIMITED. You should refer to that name for Stock Exchange Status.

Legal Status: (updated monthly)

This company subsequently changed its name to BENITEC BIOPHARMA LIMITED. You should refer to that name for Legal Status.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This company subsequently changed its name and is now BENITEC BIOPHARMA LIMITED. You should refer to that name for Capital Gains Tax Status.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

BENITEC LIMITED(BLT)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
BENITEC LIMITED	30/04/2002	25/11/2011
QUEENSLAND OPALS NL		30/04/2002

Shareholder links

REGISTRY:

Level 1, 200 Mary Street Brisbane QLD 4000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail

Company details

Address: Level 16, 356 Collins Stree, Melbourne VIC 3000
Tel: +61 (0)2 9555 6986 Fax: +61 (0)3 8678 1342

Date first listed: 17/02/1997
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biotechnology company focused on developing therapeutics to treat serious diseases

News & Events

Expand this box to read and print

name changed to Benitec Biopharma Limited	25/11/2011
the quoted options (ASX Code BLTOA) of Benitec Limited (the "Company") will be suspended from quotation at the close of trading today, Friday 25 March 2011, in accordance with listing rule 17.3.3 and Appendix 6A, pending expiry of the options on 3 April 2011. For further details please see the Company's Option Expiry Notice released on 3 March 2011	25/03/2011
the suspension of trading in the securities of Benitec Limited (the "Company") will be lifted immediately, following receipt of an announcement in relation to a Non-Final Office Action from the US Patents and Trademarks Office	21/04/2008
securities suspended from quotation pending an announcement	16/04/2008
shares reinstated to quotation	24/10/2006
the board advises that the final audited financial accounts for 2005 2006 and Directors report due to be submitted to the ASX will be further delayed - it expects to have resolution later this week	17/10/2006
the company has secured a $1 million unsecured loan from a sophisticated Australian investor - the investor Dr Chris Bremner will provide 3 installments over 12 months and the first installment of $350,000 was received overnight - the Board has agreed to allow Dr Bremner to convert the loan into shares	17/10/2006
company has secured upfront payments, a scale of milestone payments and a potential future royalty stream by licensing its gene silencing technology for treating Hepatitis C - Benitec will also receive a 5 percent equity stake in California-based Tacere Therapeutics, Inc	11/10/2006
company advises that the final audited financial accounts for 2005 / 2006 and Directors report due to be submitted to the ASX will be delayed until at least late next week	06/10/2006
securities suspended from quotation because of failure to lodge full year accounts for the period to 30 June 2006	02/10/2006
name changed from Queensland Opals NL	30/04/2002

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
18/11/2011	Melvyn Bridges	1,850,000	$0.016	$29,926.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Peter Francis	Non Exec Chairman	08/02/2006
Peter French	CEO	04/06/2010
Greg West	CFO, Company Secretary	01/08/2011
Melvyn Bridges	Executive Director	12/10/2007
John Chiplin	Executive Director	01/02/2010
Iain Ross	Director	01/06/2010
Michael Dalling	Director

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.